What this page covers
Flexbone works alongside OncoEMR, Flatiron Health's cloud-based oncology EMR, by operating in the same web interface your staff use, not through a native or certified integration. Community oncology practices run regimens, orders, and infusion schedules in OncoEMR, and a new treatment plan usually triggers payer work: a benefits investigation for buy-and-bill drugs billed under the medical benefit with J codes, prior authorization for the regimen and its supportive drugs, and the scheduling calls around chair time. Flexbone browser agents run the 270/271 eligibility check and the benefits investigation, submit and track the 278 authorization, and work denials by CARC code, and voice agents place the payer and patient calls.
OncoEMR and the teams it serves
OncoEMR is Flatiron Health's cloud-based oncology EMR, used by community oncology practices and cancer centers to manage treatment regimens, orders, visit documentation, and the infusion schedule. The oncology revenue cycle concentrates risk in the drugs. In a buy-and-bill practice the clinic purchases infusion drugs up front and bills the medical benefit with J codes after administration, so an incomplete benefits investigation or a missing authorization puts the practice's own drug spend at risk, not just a visit fee. Authorizations attach to the treatment plan, and a regimen change mid-course often means a new one. Flexbone works alongside OncoEMR by operating in the same web interface your financial coordinators and billers already use, with no native or certified integration; the browser agents drive the screens a person would.
Get an outside read on your oncoemr workflow
In 30 minutes we map your current volume, the payers and systems involved, where staff time goes, and the highest-ROI calls and follow-ups Flexbone can take off your team first, scoped to the work you actually run.
Front and back office workflows Flexbone runs
Before the first infusion, Flexbone runs the 270/271 eligibility check and the benefits investigation: whether the drug falls under the medical or pharmacy benefit, site-of-care rules, deductible and coinsurance position, and the patient responsibility the practice should collect or route to assistance programs. Browser agents submit the 278 prior authorization for the regimen and its supportive drugs, track it to a decision, and start a new request when the treatment plan changes. Voice agents place the payer calls a portal cannot answer, confirm infusion appointments, and reschedule missed chair time. Denials route by CARC and RARC code from the 835. The detail lives on the eligibility verification, prior authorization, and denials management pages, and the EHR integrations page covers the browser-agent mechanism.
How Flexbone works alongside OncoEMR
Flexbone is forward-deployed. We build the agents around your OncoEMR configuration, regimen mix, and payer contracts, validate them against your real benefits investigation and authorization patterns, and keep refining them. Because the agents operate in the OncoEMR web interface rather than through an integration, a completed benefits investigation, a tracked authorization, or a worked denial lands in the record your financial coordinators already use, and anything outside the agent scope is handed to a person with context. In the engagements we scope, the rollout starts with benefits investigation and treatment-plan authorization, since those sit directly in front of drug spend, then adds infusion scheduling calls and denial follow-up. We operate under HIPAA with a business associate agreement.